Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease

Figure 3 Relationship between pancreatic steatosis and metabolic dysfunction-associated steatohepatitis grade and fibrosis stage. A: Box and whiskers plot with all values included for pancreatic steatosis by metabolic dysfunction-associated steatohepatitis grade on biopsy (n = 22 for grade 0, n = 66 for grade 1, n = 11 for grade 2 and 3), Kruskal-Wallis test, P = 0.99; B: Box and whiskers plot with all values included for pancreatic steatosis by fibrosis stage on biopsy (n = 15 for stage 0, n = 20 for stage 1, n = 16 for stage 2, n = 10 for stage 3, n = 38 for stage 4), Kruskal-Wallis test, P = 0.98; C: Box and whiskers plot with all values included for pancreatic steatosis by fibrosis category [minimal 0 to 2 (n = 51) vs advanced 3 to 4 (n = 48)] on biopsy, Wilcoxon test, P > 0.99. MASH: Metabolic dysfunction-associated steatohepatitis.